<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Blood transfusions for treating acute chest syndrome in people with sickle cell disease - Dolatkhah, R - 2020 | Cochrane Library</title> <meta content="Blood transfusions for treating acute chest syndrome in people with sickle cell disease - Dolatkhah, R - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007843.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Blood transfusions for treating acute chest syndrome in people with sickle cell disease - Dolatkhah, R - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007843.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007843.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Blood transfusions for treating acute chest syndrome in people with sickle cell disease" name="citation_title"/> <meta content="Roya Dolatkhah" name="citation_author"/> <meta content="Tabriz University of Medical Sciences" name="citation_author_institution"/> <meta content="Saeed Dastgiri" name="citation_author"/> <meta content="Tabriz University of Medical Sciences" name="citation_author_institution"/> <meta content="saeed.dastgiri@gmail.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD007843.pub4" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/01/16" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007843.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007843.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007843.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Chest Syndrome [etiology, mortality, *therapy]; Anemia, Sickle Cell [*complications]; *Blood Transfusion; Randomized Controlled Trials as Topic; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007843.pub4&amp;doi=10.1002/14651858.CD007843.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="nnwvukoo";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007843\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007843\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fa","fr","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007843.pub4",title:"Blood transfusions for treating acute chest syndrome in people with sickle cell disease",firstPublishedDate:"Jan 16, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=nnwvukoo&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007843.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007843.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007843.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007843.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007843.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007843.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007843.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007843.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007843.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007843.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007843.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007843.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007843.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007843.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2952 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007843.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/full#CD007843-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/full#CD007843-sec-0078"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/full#CD007843-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/full#CD007843-sec-0036"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/full#CD007843-sec-0037"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/full#CD007843-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/full#CD007843-sec-0073"> Discussion </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/appendices#CD007843-sec-0082"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007843.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Blood transfusions for treating acute chest syndrome in people with sickle cell disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/information#CD007843-cr-0002">Roya Dolatkhah</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007843.pub4/information#CD007843-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Saeed Dastgiri</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007843.pub4/information/en#CD007843-sec-0089">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 16 January 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007843.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007843.pub4">https://doi.org/10.1002/14651858.CD007843.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007843-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007843-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007843-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007843-abs-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007843-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007843-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007843-abs-0001" lang="en"> <section id="CD007843-sec-0001"> <h3 class="title" id="CD007843-sec-0001">Background</h3> <p>Sickle cell disease is an inherited autosomal recessive blood condition and is one of the most prevalent genetic blood diseases worldwide. Acute chest syndrome is a frequent complication of sickle cell disease, as well as a major cause of morbidity and the greatest single cause of mortality in children with sickle cell disease. Standard treatment may include intravenous hydration, oxygen as treatment for hypoxia, antibiotics to treat the infectious cause and blood transfusions may be given. This is an update of a Cochrane Review first published in 2010 and updated in 2016. </p> </section> <section id="CD007843-sec-0002"> <h3 class="title" id="CD007843-sec-0002">Objectives</h3> <p>To assess the effectiveness of blood transfusions, simple and exchange, for treating acute chest syndrome by comparing improvement in symptoms and clinical outcomes against standard care. </p> </section> <section id="CD007843-sec-0003"> <h3 class="title" id="CD007843-sec-0003">Search methods</h3> <p>We searched The Cochrane Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register, which comprises references identified from comprehensive electronic database searches and handsearching of relevant journals and abstract books of conference proceedings. </p> <p>Date of the most recent search: 30 May 2019.</p> </section> <section id="CD007843-sec-0004"> <h3 class="title" id="CD007843-sec-0004">Selection criteria</h3> <p>Randomised controlled trials and quasi‐randomised controlled trials comparing either simple or exchange transfusion versus standard care (no transfusion) in people with sickle cell disease suffering from acute chest syndrome. </p> </section> <section id="CD007843-sec-0005"> <h3 class="title" id="CD007843-sec-0005">Data collection and analysis</h3> <p>Both authors independently selected trials and assessed the risk of bias, no data could be extracted. </p> </section> <section id="CD007843-sec-0006"> <h3 class="title" id="CD007843-sec-0006">Main results</h3> <p>One trial was eligible for inclusion in the review. While in the multicentre trial 237 people were enrolled (169 SCC, 42 SC, 15 Sβ⁰‐thalassaemia, 11Sβ<sup>+</sup>‐thalassaemia); the majority were recruited to an observational arm and only ten participants met the inclusion criteria for randomisation. Of these, four were randomised to the transfusion arm and received a single transfusion of 7 to 13 mL/kg packed red blood cells, and six were randomised to standard care. None of the four participants who received packed red blood cells developed acute chest syndrome, while 33% (two participants) developed acute chest syndrome in standard care arm. No data for any pre‐defined outcomes were available. </p> </section> <section id="CD007843-sec-0007"> <h3 class="title" id="CD007843-sec-0007">Authors' conclusions</h3> <p>We found only one very small randomised controlled trial; this is not enough to make any reliable conclusion to support the use of blood transfusion. Whilst there appears to be some indication that chronic blood transfusion may play a roll in reducing the incidence of acute chest syndrome in people with sickle cell disease and albeit offering transfusions may be a widely accepted clinical practice, there is currently no reliable evidence to support or refute the perceived benefits of these as treatment options; very limited information about any of the potential harms associated with these interventions or indeed guidance that can be used to aid clinical decision making. Clinicians should therefore base any treatment decisions on a combination of; their clinical experience, individual circumstances and the unique characteristics and preferences of adequately informed people with sickle cell disease who are suffering with acute chest syndrome. This review highlights the need of further high quality research to provide reliable evidence for the effectiveness of these interventions for the relief of the symptoms of acute chest syndrome in people with sickle cell disease. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007843-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007843-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007843-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007843-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007843-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007843-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007843-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007843-abs-0005" lang="en"> <h3>Blood transfusions for treating acute chest syndrome in people with sickle cell disease</h3> <p><b>Review question</b> </p> <p>We reviewed the effectiveness of blood transfusions, for treating acute chest syndrome by comparing improvement in symptoms and clinical outcomes against standard care. This is an update of a Cochrane Review first published in 2010 and updated in 2016. </p> <p><b>Background</b> </p> <p>Sickle cell disease (SCD) is an inherited blood condition affecting over 250 million people worldwide and is particularly common in Sub‐Saharan Africa, South and Central America, Saudi Arabia, India and a number of Mediterranean countries. It is characterized by the presence of sickle‐shaped red blood cells which are capable of blocking the blood vessels causing pain and severe damage to several organs of the body. People with SCD may have the acute onset of chest problems which may include fever, this is called acute chest syndrome. Treatment will depend on the individuals' clinical condition and the severity of the symptoms. Standard treatment consists of supportive care, antibiotics, intravenous fluids and blood transfusion, either simple or exchange, may also be indicated. </p> <p><b>Search date</b> </p> <p>The evidence is current to: 30 May 2019.</p> <p><b>Key results</b> </p> <p>One study was included in the review, there were two parts to the study, one larger observational study and one randomised trial which was to assess transfusion versus standard care to prevent acute chest syndrome in people with sickle cell disease, while twenty‐six centres were contracted. Only 10 participants were enrolled into the randomised trial. The effects of blood transfusions could not be determined from the trial; there were no data that could be presented or therefore analysed within this review for the very small number of participants enrolled. </p> <p>Therefore, this unique study did not show how effective blood transfusions might be for treating acute chest syndrome in people with sickle cell disease. Future research is needed to provide evidence for people to make informed decisions on whether blood transfusions are effective for treating acute chest syndrome in people with sickle cell disease. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007843-sec-0078" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007843-sec-0078"></div> <h3 class="title" id="CD007843-sec-0079">Implications for practice</h3> <section id="CD007843-sec-0079"> <p>Whilst there appears to be some indication that chronic blood transfusion may play a roll in reducing the incidence of acute chest syndrome (ACS) in people with sickle cell disease (SCD) and albeit offering transfusions may be a widely accepted clinical practice, there is currently no reliable evidence to support or refute the perceived benefits of these as treatment options; very limited information about any of the potential harms associated with these interventions or indeed guidance that can be used to aid clinical decision making. Clinicians should therefore base any treatment decisions on a combination of; their clinical experience, individual circumstances and the unique characteristics and preferences of adequately informed people with SCD who are suffering with ACS. </p> </section> <h3 class="title" id="CD007843-sec-0080">Implications for research</h3> <section id="CD007843-sec-0080"> <p>We found only one very small randomised controlled trial; this is not enough to make any reliable conclusion to support the use of blood transfusion. This review highlights the need of further high quality research in the context of randomised clinical trials to provide reliable evidence for the effectiveness of these interventions for the relief of the symptoms of ACS in people with SCD. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007843-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007843-sec-0029"></div> <section id="CD007843-sec-0030"> <h3 class="title" id="CD007843-sec-0030">Description of the condition</h3> <section id="CD007843-sec-0031"> <h4 class="title">Aetiology and prevalence</h4> <p>Sickle cell disease (SCD) is an inherited autosomal recessive blood condition in which either both sickle haemoglobin genes or one sickle haemoglobin gene with another gene of an abnormal haemoglobin, e.g. thalassaemia gene have been inherited. It is one of the most prevalent genetic blood diseases worldwide. It is particularly common in Sub‐Saharan Africa, South and Central America, Saudi Arabia, India and a number of Mediterranean countries (<a href="./references#CD007843-bbs2-0009" title="AlvimRC , VianaMB , PiresMA , FranklinHM , PaulaMJ , BritoAC , et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematologica2005;113(4):228‐33. ">Alvim 2005</a>; <a href="./references#CD007843-bbs2-0013" title="El‐HazmiM , Al‐FawazI , WarsyA , OpawoyeA , TalebH , HowsawiZ , et al. Piracetam for the treatment of sickle cell disease in children ‐ a double blind test. Saudi Medical Journal1998;19(1):22‐7. ">El‐Hazmi 1998</a>; <a href="./references#CD007843-bbs2-0017" title="FlemingAF . The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Reviews1989;3(1):18‐28. ">Fleming 1989</a>; <a href="./references#CD007843-bbs2-0024" title="LoureiroMM , RozenfeldS . Epidemiology of sickle cell disease hospital admissions in Brazil. Revista de Saúde Pública2005;39(6):943‐9. ">Loureiro 2005</a>). Annually, worldwide, there are approximately over 300,000 SCD‐affected conceptions or births (<a href="./references#CD007843-bbs2-0027" title="PielFB , PatilAP , HowesRE , NyangiriOA , GethingPW , DewiM , et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model‐based map and population estimates. Lancet2012;381(9861):142‐51. ">Piel 2012</a>). </p> <p>Abnormal haemoglobin genes inherited from both parents are responsible for several different forms of the disease. The most commonly seen types of SCD include homozygous sickle cell (SS), a disease in which the sickle haemoglobin (HbS) gene is inherited from both parents; sickle cell‐haemoglobin C (SC) disease in which the genes for HbS and HbC are inherited; and two further types resulting from the interaction of HbS genes with those for beta thalassaemia; sickle cell/βo ‐thalassaemia and sickle cell/β+ thalassaemia (Sβ<sup>0</sup> and Sβ+). Homozygous sickle cell (SS) disease and sickle cell/βo ‐thalassaemia are generally considered the more severe forms of the disease whilst SC disease and sickle cell/β+ thalassaemia tend to be milder. </p> <p>The main clinical features result from the tendency of HbS molecules to polymerise, leading to a reduced pliability of the red blood cells which are then prematurely broken down and eventually cause blockages and reduced flow in some of the blood vessels (vaso‐occlusion). Chronic haemolytic anaemia, increased susceptibility to infections, recurrent episodes of pain, an increased risk of stroke and multiple organ dysfunction are some of the potentially serious complications in SCD (<a href="./references#CD007843-bbs2-0026" title="NjamnshiAK , MbongEN , WonkamA , Ongolo‐ZogoP , DjientcheuVD , SunjohFL , et al. The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon. Journal of Neurological Sciences2006;250(1‐2):79‐84. ">Njamnshi 2006</a>; <a href="./references#CD007843-bbs2-0029" title="SergeantGR . Natural history and determinants of clinical severity of sickle cell disease. Current Opinion in Hematology1995;2(2):103‐8. ">Serjeant 1995</a>). </p> <p>Acute chest syndrome (ACS) is a frequent complication of SCD, as well as a major cause of morbidity and the greatest single cause of mortality in SCD from the age of two years (<a href="./references#CD007843-bbs2-0035" title="VichinskyEP , NeumayrLD , EarlesAN , WilliamsR , LennetteET , DeanD , et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine2000;342(25):1855‐65. ">Vichinsky 2000</a>). An infectious agent is identified in more than one third of the cases, however, because of the life‐threatening nature of the syndrome, broad antibiotic therapy is usually administered, even if infection was not the clear etiology. Hypoxemia in ACS is postulated to be due to sickling in the pulmonary vasculature which results in a ventilation and perfusion mismatch (<a href="./references#CD007843-bbs2-0015" title="EmreU , MillerST , GutierezM , SteinerP , RaoSP , RaoM . Effect of transfusion in acute chest syndrome of sickle cell disease. Journal of Pediatrics1995;127(6):901‐4. ">Emre 1995</a>). </p> <p>Data from the Clinical Course of Sickle Cell Disease Cooperative Study indicate that ACS occurs with a rate of 10.5 per 100 patients per year (<a href="./references#CD007843-bbs2-0011" title="CastroO , BrambillaDJ , ThoringtonB , ReindorfCA , ScottRB , GilletteP , et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood1994;84(2):643‐9. ">Castro 1994</a>). </p> </section> <section id="CD007843-sec-0032"> <h4 class="title">Symptoms and diagnosis</h4> <p>Acute chest syndrome has been defined as a new infiltrate visible on chest radiograph associated with one or more symptoms, such as fever, cough, sputum production, tachypnoea, dyspnoea (breathing difficulties), or new‐onset hypoxia (poor oxygenation) (<a href="./references#CD007843-bbs2-0035" title="VichinskyEP , NeumayrLD , EarlesAN , WilliamsR , LennetteET , DeanD , et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine2000;342(25):1855‐65. ">Vichinsky 2000</a>). Complications occurring in the lungs include infection and infarction (death of tissue due to blockage of the blood vessels by blood clots or bone marrow fat), and whilst infection occurs predominately in children and infarction more commonly in adults, these two are often interrelated and may occur concurrently (<a href="./references#CD007843-bbs2-0033" title="TaylorC , CarterF , PouloseJ , RolleS , BabuS , CrichlowS . Clinical presentation of acute chest syndrome in sickle cell disease. Postgraduate Medical Journal2004;80(944):346‐9. ">Taylor 2004</a>). Rates of infection have been reported as: chlamydia 7.2%; mycoplasma 6.6%; viruses 6.4%; and <i>Streptococcus pneumoniae</i>, 4.3% (<a href="./references#CD007843-bbs2-0035" title="VichinskyEP , NeumayrLD , EarlesAN , WilliamsR , LennetteET , DeanD , et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine2000;342(25):1855‐65. ">Vichinsky 2000</a>). A further complication is the acute fragmentation of red blood cells (haemolysis) in the pulmonary vessels. Recurrent attacks of ACS may also result in pulmonary fibrosis, pulmonary hypertension, and right‐sided heart failure. </p> <p>Symptoms and complications of ACS may vary quite widely between people with SCD. The severity of the clinical manifestations varies from one person to another according to the general health state, age and the etiology of a particular episode of ACS. Some individuals face a higher risk of mortality, while others have a longer life expectancy once they receive good medical care (<a href="./references#CD007843-bbs2-0019" title="GoldenC , StylesL , VichinskyE . Acute chest syndrome and sickle cell disease. Current Opinion in Hematology1998;5(2):89‐92. ">Golden 1998</a>; <a href="./references#CD007843-bbs2-0034" title="VichinskyEP , StylesLA , ColangeloLH , WrightEC , CastroO , NickersonB . Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood1997;89(5):1787‐92. ">Vichinsky 1997</a>). The treatment strategies will therefore need to be modified and different decisions needed to be made by individual patient status. </p> </section> </section> <section id="CD007843-sec-0033"> <h3 class="title" id="CD007843-sec-0033">Description of the intervention</h3> <p>Management of ACS depends on the individuals' clinical condition and presenting complaint. Standard treatment is intravenous hydration to maintain the individuals' euvolemic especially in the presence of dehydration, oxygen as treatment for hypoxia and antibiotics to treat the infectious cause and often blood transfusion (<a href="./references#CD007843-bbs2-0015" title="EmreU , MillerST , GutierezM , SteinerP , RaoSP , RaoM . Effect of transfusion in acute chest syndrome of sickle cell disease. Journal of Pediatrics1995;127(6):901‐4. ">Emre 1995</a>). Other treatment modalities include vasodilation, anticoagulation, inhaled nitrous oxide (<a href="./references#CD007843-bbs2-0008" title="Al HajeriA , SerjeantGR , FedorowiczZ . Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD006957] ">Al Hajeri 2008</a>), antibiotics (<a href="./references#CD007843-bbs2-0025" title="Martí‐CarvajalAJ , ConternoLO , Knight‐MaddenJM . Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews2019, Issue 9. [DOI: 10.1002/14651858.CD006110.pub2] ">Martí‐Carvajal 2019</a>) and inhaled bronchodilators (<a href="./references#CD007843-bbs2-0023" title="Knight‐MaddenJM , HambletonIR . Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews2016, Issue 9. [DOI: 10.1002/14651858.CD003733] ">Knight‐Madden 2016</a>). Dexamethasone was previously also used as an alternative treatment (<a href="./references#CD007843-bbs2-0010" title="BerniniJC , RogersZR , SandlerES , ReischJS , QuinnCT , BuchananGR . Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood1998;92(9):3082‐9. ">Bernini 1998</a>); but a recent study has shown an increased duration of admission and risk of re‐admission in children treated with dexamethasone for ACS, so this is no longer recommended (<a href="./references#CD007843-bbs2-0031" title="StrouseJJ , TakemotoCM , KeeferJR , KatoGJ , CasellaJF . Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatric Blood Cancer2008;50(5):1006‐12. ">Strouse 2009</a>). In SCD, transfusion may prevent complications (<a href="./references#CD007843-bbs2-0015" title="EmreU , MillerST , GutierezM , SteinerP , RaoSP , RaoM . Effect of transfusion in acute chest syndrome of sickle cell disease. Journal of Pediatrics1995;127(6):901‐4. ">Emre 1995</a>). There are two modalities of red cell transfusion, simple and exchange transfusion. The vast majority of transfusions for SCD are simple red cell transfusions, which are useful when added oxygen capacity is needed and in conditions where the haemoglobin has dropped to a level significantly below the steady state (<a href="./references#CD007843-bbs2-0032" title="SwerdlowPS . Red cell exchange in sickle cell disease. Hematology / the Education Program of the American Society of Hematology2006;2006(1):48‐53. ">Swerdlow 2006</a>). Red cell exchange transfusion is an effective but perhaps under‐utilised treatment for both acute and chronic complications of SCD. It is given in severe or rapidly progressive illness, when the individuals Hb is 10 gm or more and the HbS is greater than 30%. Recently a review article published by Farooq emphasized the indication of chronic transfusion therapy in recurrent episodes of moderate‐to‐severe ACS in sickle cell crises, to maintain the haemoglobin S percentage below 50% (<a href="./references#CD007843-bbs2-0016" title="FarooqS , Abu OmarM , SalzmanGA . Acute chest syndrome in sickle cell disease. Hospital Practice2018;46(3):144–51. ">Farooq 2018</a>). This idea has been evidenced previously in the Stroke Prevention Trial (STOP) trial, which showed that chronic transfusion therapy decreased the incidence of ACS, and prevented secondary stroke in sickle cell crises (<a href="./references#CD007843-bbs2-0005" title="AbboudM , CureJ , GallagherD , BermanB , HsuL , WangW , et al. Magnetic resonance angiography (MRA) in children with abnormal transcranial doppler (TCD) velocities in the STOP study. Blood1999;94(10 Suppl 1):645a. AbboudMR , CureJ , GallagherD , BermanB , HsuL , WangW , et al. Magnetic resonance angiography in children with abnormal TCD in the STOP study. 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:49. AbboudMR , CureJ , GrangerS , GallagherD , HsuL , WangW , et al. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood2004;103(7):2822‐6. AdamkiewiczT , AbboudM , BarredoJ , CavalierME , PetersonJ , RackoffB , et al. Serum Ferritin in children with SCD on chronic transfusion: correlation with serum alanine aminotransferase and liver iron (STOP/STOP II liver iron ancillary study). 35th Annivesary Convention of the National Sickle Celll Disease Program and the Sickle Cell Disease Association of America; 2007 Sep 17‐22; Washington DC, USA. 2007:316. AdamkiewiczT , AbboudMR , BarredoJC , Kirby‐AllenM , AlvarezOA , CasellaJF , et al. Serum ferritin in children with sickle cell disease on chronic transfusion: measure of iron overload or end organ injury? STOP/ STOP II liver iron ancillary study. Blood. 2006; Vol. 108, issue 11. [Abstract no: 791] AdamkiewiczTV , AbboudMR , PaleyC , OlivieriN , Kirby‐AllenM , VichinskyE , et al. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood2009;114(21):4632‐8. AdamsR , FullertonH , KwiatkowskiJ , VoeksJ . Development of high risk TCD in sickle cell disease. Stroke; a journal of cerebral circulation2015;46(Suppl 1):Abstract no: 17. AdamsRJ . Lessons from the stroke prevention trial in sickle cell anemia (STOP) study. Journal of Child Neurology2000;15(5):344‐9. [NCT00000592: Stroke Prevention in Sickle Cell Anemia (STOP 1)] AdamsRJ , BrambillaDJ . Stroke prevention trial in sickle cell anemia: STOP. 21st Annual Meeting of the National Sickle Cell Disease Program. 1996:19. AdamsRJ , BrambillaDJ , GrangerS , GallagherD , VichinskyE , AbboudMR , et al. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood2004;103(10):3689‐94. AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Risk of stroke in children with sickle cell disease and abnormal transcranial doppler ultrasound (TCD). Blood1999;94(10 Suppl 1):419a. AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): Baseline characteristics of trial patients. 22nd Annual Meeting of the National Sickle Cell Disease Program. 1997:41. AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): final results. 25th Annual Meeting of the National Sickle Cell Disease Program. 2001. [Abstract no: #8] AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): final results. Blood2000;96(11 Pt 1):10a. AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): follow‐up after closure of the trial. Blood1998;92(10 Suppl 1):527a. AdamsRJ , BrambillaDJ , McKieVC , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): baseline characteristics of trial patients. Blood1997;90(10 Suppl 1):123a. AdamsRJ , BrambillaDJ , VichinskyE , AbboudM , PegelowC , CarlEM , et al. Risk of stroke and conversion to abnormal TCD in children screened with transcranial doppler (TCD) during the STOP study. National Sickle Cell Disease Program 30th Annual Meeting; 2002 Sept 17‐21. 2002:3. AdamsRJ , BrambillaDJ , VichinskyE , AbboudM , PegelowC , CarlEM , et al. Stroke prevention trial in sickle cell anemia (STOP study): Risk of stroke in 1933 children screened with transcranial doppler (TCD). 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:54. AdamsRJ , CarlEM , McKieVC , OdoNA , KutlarA , PhillipsM , et al. A pilot trial of hydroxyurea to prevent strokes in children with sickle cell anemia. 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:53. AdamsRJ , LacklandDT , BrownL , BrownD , VoeksJ , FullertonHJ , et al. Transcranial Doppler Re‐screening of Subjects who Participated in STOP and STOP. American journal of hematology2016;91(12):1191‐4. AdamsRJ , McKieV , FilesB , VichinskyE , AbboudM , HsuL , et al. Stroke prevention in sickle cell disease (STOP): Results of transcranial doppler ultrasound screening stroke risk. Stroke1998;29(1):308. AdamsRJ , McKieVC , BrambillaDJ , CarlE , GallagherD , NicholsFT , et al. Stroke prevention trial in sickle cell anemia. Controlled Clinical Trials1998;19(1):110‐29. AdamsRJ , McKieVC , HsuL , FilesB , VichinskyE , PegelowC , et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. New England Journal of Medicine1998;339(1):5‐11. [NCT00000592: Stroke Prevention in Sickle Cell Anemia (STOP 1)] Anonymous . Transfusion to prevent first stroke in children with sickle cell anemia. Journal of the American Ostoepathic Association1998;98(7):363‐4. BulasDI , JonesA , SeibertJJ , DriscollC , O'DonnellR , AdamsRJ . Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatric Radiology2000;30(11):733‐8. CohenAR . Sickle cell disease ‐ new treatments, new questions. New England Journal of Medicine1998;339(1):42‐4. DuncanGW . Ischemic stroke in sickle cell disease: a review. Tennessee Medicine1997;90(12):498‐9. FilesB , BrambillaD , KutlarA , MillerS , PegelowC , VichinskyE , et al. A randomized trial of chronic transfusion to prevent stroke in sickle cell anemia: changes in ferritin with chronic transfusion. Blood1998;92(10 Suppl 1):528a. FilesB , BrambillaD , KutlarA , MillerS , VichinskyE , WangW , et al. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). Journal of Pediatric Hematology/Oncology2002;24(4):284‐90. GatesA , RogersMA , PuczynskiM . Stroke prevention trial in sickle cell anemia: comments on effects of chronic transfusion on pain. Journal of Pediatrics2002;141(5):742‐3. HsuLL , MillerST , WrightE , KutlarA , McKieV , WangW , et al. Alpha thalassemia is associated with decreased risk of abnormal transcranial doppler ultrasonography in children with sickle cell anemia. Journal of Pediatric Hematology/Oncology2003;25(8):622‐8. HyacinthHI , GeeBE , VoeksJH , AdamsRJ , HibbertJ . High frequency of RBC transfusions in the STOP study was associated with reduction in serum biomarkers of neurodegeneration, vascular remodeling and inflammation. Blood. 2012; Vol. 120, issue 21. [Abstract no: 244; CENTRAL: 999896; CRS: 5500127000000021] KanterJ , KwiatkowskiJ , FullertonHJ , VoeksJ , DebenhamE , BrownLJ , et al. Impact of TCD screening protocol on the incidence of hemorrhagic stroke in children and young adults with sickle cell disease. Blood2015;126(23):3402. KutlarA , BrambillaD , ClairB , HaghighatA , BakanayS , AdamsG , et al. Candidate gene polymorphisms and their association with TCD velocities in children with sickle cell disease. Blood. 2007; Vol. 110, issue 11. [Abstract no: 429] KutlarA , HarbinJ , JacksonB , HolleyL , GallagherD , ClairB , et al. Laboratory parameters in patients randomized in the STOP study and their modification by transfusion. Blood2000;96(11 Pt 2):18b‐9b. KutlarA , HarbinJ , JacksonBB , HolleyLGD , ClairB , BrambillaD , et al. Baseline laboratory parameters in patients randomized to the STOP study and their modification by transfusion. 24th Annual Meeting of the National Sickle Cell Disease Program. 2000:82a. KwiatkowskiJL , BrambillaDJ , GrangerS , AdamsRJ . Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease. Blood. 2003; Vol. 102, issue 11. [Abstract no: 408] KwiatkowskiJL , GrangerS , BrambillaDJ , BrownRC , MillerST , AdamsRJ . Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. British Journal of Haematology2006;134(3):333‐9. KwiatkowskiJL , KanterJ , FullertonHJ , VoeksJ , DebenhamE , BrownDG , et al. Ischemic stroke in children and young adults with sickle cell disease (SCD) in the post‐stop era. Blood2015;126(23):68. [CFGD Register: SC4fff, SC185q] KwiatkowskiJL , MoralesK , BrambillaDJ , FilesB , AdamkiewiczT , AdamsRJ . Long‐term follow‐up of transcranial doppler ultrasonography in children with sickle cell disease: Results of the STOP and STOP II patient cohorts. Blood2002;100(11 Pt 1):663a. LeeMT , PiomelliS , GrangerS , MillerST , HarknessS , BrambillaDJ , et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow‐up and final results. Blood2006;108(3):847‐52. LeeSB , RamsinghD , KutlarA , HolleyL , McVieVC , AdamsRJ . C‐reactive protein in children with sickle cell disease at risk for stroke in the STOP study. Stroke2002;33(1):373. LezcanoNE , OdoN , KutlarA , BrambillaD , AdamsRJ . Regular transfusion lowers plasma free hemoglobin in children with sickle‐cell disease at risk for stroke. Stroke2006;37(6):1424‐6. [CFGD Register: SC4uu] LezcanoNE , OdoN , KutlarA , BrambillaD , AdamsRJ . Transfusion lowers plasma‐free hemoglobin in children with sickle cell disease at risk for stroke. Stroke2006;37(2):695‐6. [CFGD Register: SC4ggg] MillerST , WrightE , AbboudM , BermanB , FilesB , ScherC , et al. Impact of chronic transfusion on non‐neurological events during the Stroke Prevention Trial in sickle cell anemia (STOP). Pediatric Research2000;47(4 Pt 2):251A. MillerST , WrightE , AbboudM , BermanB , FilesB , ScherC , et al. Impact of chronic transfusion on non‐neurological events during the stroke prevention trial in sickle cell anemia (TOP). 24th Annual Meeting of the National Sickle Cell Disease Program. 2000:61a. MillerST , WrightE , AbboudM , BermanB , FilesB , ScherCD , et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle‐cell anemia. Journal of Pediatrics2001;139(6):785‐9. NicholsFT , JonesAM , AdamsRJ . Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing. Journal of Neuroimaging2001;11(4):354‐62. OlivieriN , BrambillaD , McKieV , PiomelliS , KutlarA , FilesB , et al. Changes in cerebral blood flow velocities during chronic transfusion therapy to prevent stroke in sickle cell disease. Blood2000;96(11 Pt 1):486a. PegelowCH , AdamsR , HsuL , McKieV , WangW , ZimmermanR , et al. Children with silent infarct and elevated transcranial doppler ultrasonography velocity are at increased risk of subsequent infarctive events. 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:137. PegelowCH , WangW , GrangerS , HsuLL , VichinskyE , MoserFG , et al. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Archives of Neurology2001;58(12):2017‐21. SarnaikSA . Prevention of stroke by transfusions in children with sickle cell anemia. New England journal of medicine1998;339:1477‐8. SayerG , BowmanL , ClairB , CailA , BlanchardB , NatrajanK , et al. Long term outcome of patients enrolled into STOP and STOP II trials: a single center experience. Blood. 2012; Vol. 120, issue 21. [Abstract no: 3219; CENTRAL: 999895; CRS: 5500127000000020] StylesL , DeJongK , VichinskyE , LubinB , AdamsR , KuypersF . Increased RBC phosphatidylserine exposure in sickle cell disease patients at risk for stroke by transcranial Doppler screening. Blood1997;90(10 Suppl 1):604a‐5a. VichinskyE , LubanE , WrightE , OlivieriN , DriscollC , PegelowC , et al. Prospective red cell phenotype matching in STOP ‐ a multi‐centre transfusion trial. 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:163. VichinskyE , LubanN , WrightE , OlivieriN , DriscollC , PegelowC , et al. Prospective red cell phenotype matching in STOP ‐ a multi‐center transfusion trial. Blood1998;92(10 Suppl 1):528a. VichinskyEP , LubanNL , WrightE , OlivieriN , DriscollC , PegelowCH , et al. Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion2001;41(9):1086‐92. WangW , MoralesK , OlivieriN , StylesL , ScherC , AdamsR , et al. Effect of chronic transfusion on growth in children with sickle cell anemia: results of the STOP trial. National Sickle Cell Disease Program 30th Annual Meeting Conference; 2002 Sept 17‐21. 2002:100. WangWC , MoralesKH , ScherCD , StylesL , OlivieriN , AdamsR , et al. Effect of long‐term transfusion on growth in children with sickle cell anemia: results of the STOP trial. Journal of Pediatrics2005;147(2):244‐7. ">STOP 1998</a>). </p> </section> <section id="CD007843-sec-0034"> <h3 class="title" id="CD007843-sec-0034">How the intervention might work</h3> <p>Simple red cell transfusions consist of packed red cells administered intravenously. Hemoglobin concentration and blood viscosity is noted to increase after simple transfusions unless there is rapid cell destruction or bleeding (<a href="./references#CD007843-bbs2-0018" title="GladwinMT , SchechterAN , ShelhamerJH , OgnibeneFP . The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment. American Journal of Respiratory and Critical Care Medicine1999;159(5):1368‐1376. ">Gladwin 1999</a>). Simple blood transfusion is given if there is a moderate to severe illness and the haemoglobin is greater than 1 mg/dL below baseline. </p> <p>The goal of exchange transfusion is to remove the sickled cells (HbS) and replace them with adult haemoglobin (HbA) which also contributes to reducing the blood viscosity (<a href="./references#CD007843-bbs2-0035" title="VichinskyEP , NeumayrLD , EarlesAN , WilliamsR , LennetteET , DeanD , et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine2000;342(25):1855‐65. ">Vichinsky 2000</a>). In a red cell exchange, the individuals red cells are removed and replaced by exogenous normal red cells. The exchange prevents the removed sickle cells from participating in new vaso‐occlusive events, reduces haemolytic complications, and provides added oxygen carrying capacity while decreasing the blood viscosity. It is given in severe or rapidly progressive illness, when the individuals Hb is 10 gm or more and the HbS is greater than 30%. </p> </section> <section id="CD007843-sec-0035"> <h3 class="title" id="CD007843-sec-0035">Why it is important to do this review</h3> <p>Clinical standards and guidelines in the UK and USA strongly recommend the exchange transfusion method for treating symptomatic severe acute chest syndrome in people with SCD (<a href="./references#CD007843-bbs2-0036" title="YawnBP , BuchananGR , Afenyi‐AnnanAN , BallasSK , HassellKL , JamesAH , et al. Management of sickle cell disease: summary of the 2014 evidence‐based report by expert panel members. JAMA2014;312(10):1033‐48. ">Yawn 2014</a>), but the quality of evidence in this area is still low, with a very small number of RCTs looking at the routine management of ACS (<a href="./references#CD007843-bbs2-0036" title="YawnBP , BuchananGR , Afenyi‐AnnanAN , BallasSK , HassellKL , JamesAH , et al. Management of sickle cell disease: summary of the 2014 evidence‐based report by expert panel members. JAMA2014;312(10):1033‐48. ">Yawn 2014</a>). A systematic review is needed to identify and assess the evidence, and to then impact on new research programs for the use of blood transfusions for treating acute chest syndrome in people with SCD. This is an update of a Cochrane Review first published in 2010 and updated in 2016. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007843-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007843-sec-0036"></div> <p>To assess the effectiveness of blood transfusions, simple and exchange, for treating ACS by comparing improvement in symptoms and clinical outcomes against standard care. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007843-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007843-sec-0037"></div> <section id="CD007843-sec-0038"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007843-sec-0039"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) and quasi‐randomised trials.</p> </section> <section id="CD007843-sec-0040"> <h4 class="title">Types of participants</h4> <p>People with SCD: SS; SC; Sβ<sup>0;</sup> Sβ; Sβ+ (confirmed by electrophoresis and sickle solubility test, with family studies or DNA tests as appropriate) of all ages and both sexes with ACS, in any setting. </p> <p>The definition of ACS was according to the clinical signs, symptoms and criteria described by Vichinsky as; a new infiltrate visible on chest radiograph associated with one or more symptoms, such as fever, cough, sputum production, tachypnoea, dyspnoea, or new‐onset hypoxia (<a href="./references#CD007843-bbs2-0035" title="VichinskyEP , NeumayrLD , EarlesAN , WilliamsR , LennetteET , DeanD , et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine2000;342(25):1855‐65. ">Vichinsky 2000</a>). </p> </section> <section id="CD007843-sec-0041"> <h4 class="title">Types of interventions</h4> <p>Simple and red cell exchange transfusions during the ACS period, would be considered separately: </p> <p> 1. simple transfusion versus standard care (no transfusion);</p> <p> 2. exchange transfusion versus standard care (no transfusion).</p> </section> <section id="CD007843-sec-0042"> <h4 class="title">Types of outcome measures</h4> <section id="CD007843-sec-0043"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD007843-list-0001"> <li> <p>Chest pain</p> <ol id="CD007843-list-0002"> <li> <p>intensity (expressed as scores obtained through any validated patient‐reported outcomes instrument either generic or SCD specific) </p> </li> <li> <p>duration from time of start of symptoms</p> </li> </ol> </li> <li> <p>Fever</p> </li> <li> <p>Mortality</p> </li> </ol> </p> </section> <section id="CD007843-sec-0044"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD007843-list-0003"> <li> <p>Duration of any assisted ventilation</p> </li> <li> <p>Duration of hospitalisation in the intensive care unit (ICU) (number of inpatient days) </p> </li> <li> <p>Mean duration of opoid therapy</p> </li> <li> <p>Laboratory investigations:</p> <ol id="CD007843-list-0004"> <li> <p>concentration of haemoglobin S</p> </li> <li> <p>pulmonary function tests</p> </li> <li> <p>pulse oximetry to diagnose hypoxia</p> </li> </ol> </li> <li> <p>Quality of life (e.g. absence from school, lost time at work, mobility) as assessed by any validated questionnaire either generic or SCD specific </p> </li> <li> <p>Participant satisfaction with the intervention assessed by any appropriate and validated questionnaire (either generic or SCD specific) </p> </li> </ol> </p> </section> <section id="CD007843-sec-0045"> <h5 class="title">Adverse effects</h5> <p>We intended reporting on any specific adverse effects, systemic or local, toxicity, any clinically diagnosed hypersensitivity or other unacceptable or adverse events associated with this intervention. </p> </section> </section> </section> <section id="CD007843-sec-0046"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007843-sec-0047"> <h4 class="title">Electronic searches</h4> <p>We conducted searches in the Cochrane Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register using the terms: sickle cell AND acute chest syndrome. </p> <p>The Haemoglobinopathies Trials Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (Clinical Trials) (updated each new issue of the Cochrane Library) and weekly searches of MEDLINE. Unpublished work is identified by searching the abstract books of five major conferences: the European Haematology Association conference; the American Society of Hematology conference; the British Society for Haematology Annual Scientific Meeting; the Caribbean Public Health Agency Annual Scientific Meeting (formerly the Caribbean Health Research Council Meeting); and the National Sickle Cell Disease Program Annual Meeting. For full details of all searching activities for the register, please see the relevant section of the Cochrane Cystic Fibrosis and Genetic Disorders Group's <a href="http://cfgd.cochrane.org/our-specialised-trials-registers" target="_blank">website</a>. </p> <p>Date of the last search: 30 May 2019.</p> <p>We also searched the ClinicalTrials.gov database (<a href="http://www.ClinicalTrials.gov" target="_blank">www.ClinicalTrials.gov</a>) and the WHO ICTRP database (<a href="http://www.who.int/ictrp/search/en/" target="_blank">www.who.int/ictrp/search/en/</a>) in an effort to identify any additional relevant clinical studies and registered clinical trials of the same topic. Regarding the relatively high prevalence of hereditary SCD (SS) and others associated disorders in south provinces of Iran (<a href="./references#CD007843-bbs2-0037" title="ZandianKM , PedramM , KiekhaieB , ValaviA , Kianpour GhahfarokhiF . Assessing clinical laboratory funding of sickle cell disease and other associated disorders in Khuzestan province. Apadana Journal of Clinical Research2012;1:21‐5. ">Zandian 2012</a>), we tried to find any additional RCT studies registered in Iranian Registry of Clinical Trials (<a href="http://www.irct.ir" target="_blank">www.irct.ir</a>). </p> </section> <section id="CD007843-sec-0048"> <h4 class="title">Searching other resources</h4> <p>We contacted the trial authors of the PROACTIVE trial for further data and information, but to date have received no response (<a href="./references#CD007843-bbs2-0001" title="MillerST , KimHY , WeinerDL , WagerCG , GallagherD , StylesLA , et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion2013;53(4):704‐9. [CFGD Register: SC224c; 5500100000011225] NCT00951808 . Preventing Acute Chest Syndrome by Transfusion Feasibility Study (PROACTIVE). https://clinicaltrials.gov/ct2/show/NCT00951808 (accessed 03 February 2016). StylesL , Greene WagerC , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the predictive value of secretory phospholipase A2 in sickle cell disease patients with acute chest syndrome. Proceedings of the 53rd ASH Annual Meeting and Exposition; 2011 Dec 10‐13; San Diego, California. 2011. [Abstract No.: 846; CFGD Register: SC224a; 5500100000010732] StylesL , WagerCG , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). British Journal of Haematology2012;157(5):627‐36. [CFGD Register: SC224b; 5500100000010598] ">PROACTIVE 2012</a>). </p> <p>For future updates, if further trials become available we will attempt to contact investigators of these trials by either conventional or electronic mail to ask for details of additional published and unpublished trials. The reference lists of any clinical trials identified will be cross checked and the review authors' personal databases examined in an attempt to identify any other relevant trials. </p> <p>There would have been no language restrictions on included trials and if necessary the authors would have arranged to translate and report any relevant non‐English papers. </p> </section> </section> <section id="CD007843-sec-0049"> <h3 class="title" id="CD007843-sec-0049">Data collection and analysis</h3> <section id="CD007843-sec-0050"> <h4 class="title">Selection of studies</h4> <p>Two authors independently assessed the abstracts of trials identified from the searches. We obtained full copies of all potentially relevant trials, i.e. those appearing to meet the inclusion criteria, or for which there were insufficient data in the title and abstract to make a clear decision. The two review authors independently assessed the full text papers independently and resolved any disagreement on their eligibility for this review through discussion and consensus; or if necessary through a third party (an editor from the Cochrane Cystic Fibrosis and Genetic Disorders Group). After assessment, the authors eliminated from further review any remaining trials that did not match the inclusion criteria and noted the reasons for their exclusion in the '<a href="./references#CD007843-sec-0095" title="">Characteristics of excluded studies</a>' table. </p> </section> <section id="CD007843-sec-0051"> <h4 class="title">Data extraction and management</h4> <p>The following methods of data extraction, assessment of risk of bias and data management will apply for subsequent updates, if any further trials are identified. </p> <p>Data will be collected using a predetermined form designed for this purpose. Trial details will be entered into the '<a href="./references#CD007843-sec-0094" title="">Characteristics of included studies</a>' table and extracted data will be entered separately by each of two review authors into the 'Data and analyses' table in Review Manager 5 and automatically checked for differences (<a href="./references#CD007843-bbs2-0028" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We will only include data if there is an independently reached consensus and any disagreements will be discussed and if required a third review author will be consulted. </p> <p>The following details will be extracted.</p> <p> <ol id="CD007843-list-0005"> <li> <p>Trial methods: method of allocation; masking of participants; exclusion of participants after randomisation; and proportion of and reasons for follow‐up losses. </p> </li> <li> <p>Participants: country of origin; sample size; age; sex; inclusion and exclusion criteria as described in the <a href="#CD007843-sec-0038">Criteria for considering studies for this review</a>. </p> </li> <li> <p>Intervention: type; frequency; and duration of usage.</p> </li> <li> <p>Control: type; dose and frequency of any comparison or placebo.</p> </li> <li> <p>Outcomes: primary and secondary outcomes as described in the outcome measures section of this protocol. </p> </li> </ol> </p> <p>If stated, the sources of funding of any of the included trials will be recorded.</p> <p>This information will be used to help assess heterogeneity and the external validity of the trials. </p> <p>We will focus on outcomes assessments at the following time points: 24 hours, 48 to 72 hours and one month post intervention. Data, if available, will be grouped accordingly prior to analysis. If data are reported at other time periods, consideration will be given to examining these as well. </p> </section> <section id="CD007843-sec-0052"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For future updates, when more trials are included, both review author will assess every trial using a simple form and will follow the domain‐based evaluation as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007843-bbs2-0021" title="HigginsJPT , AltmanDG , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). The assessments will be compared and any inconsistencies between the review authors in the interpretation of inclusion criteria and their significance to the selected trials will be discussed and resolved. </p> <p>Each trial will be assessed as having either a low, unclear or high risk of bias in relation to the following domains. </p> <section id="CD007843-sec-0053"> <h5 class="title">1. Randomisation</h5> <p>Those assessed as having a low risk of bias in this domain will include, e.g. methods such as: computer generated or table of random numbers, drawing of lots, coin‐toss, shuffling cards or throw of a dice. We will assess those as having an unclear risk of bias, where trials are reported as being randomised, but where no description of the methods used to allocate participants to treatment group was described. We will judge trials as having a high risk of bias where methods of randomisation such as use of case record number, date of birth, or alternate numbers are used. </p> </section> <section id="CD007843-sec-0054"> <h5 class="title">2. Concealment of allocation</h5> <p>Those assessed as having a low risk of bias in this domain will include, e.g. those who have used of a central independent randomisation unit or sequentially numbered sealed opaque envelopes. We will assess as unclear those trials where the method used to conceal the allocation was either not described, or not described in sufficient detail to enable a judgement to be made. We will judge trials to have a high risk of bias in this domain if there was an open allocation sequence and the participants and trial investigators could potentially foresee the upcoming assignment. </p> </section> <section id="CD007843-sec-0055"> <h5 class="title">3. Blinding (of participants, personnel and outcome assessors)</h5> <p>Those assessed as having a low risk of bias in this domain will include no blinding (where a judgement is made that the outcome and outcome assessment are not likely to be influenced by lack of blinding) and blinding of participants and key trial personnel ensured, and unlikely that blinding could have been broken. We will assess trials as unclear where there is insufficient information to permit judgement of low or high risk or where the trial did not address the outcome. We will judge trials as having a high risk of bias in this domain, e.g. where there has been no blinding or incomplete blinding, and the outcome assessment is likely to be influenced by this; or where blinding of key trial participants and personnel attempted, but likely that it was broken. </p> </section> <section id="CD007843-sec-0056"> <h5 class="title">4. Incomplete outcome data</h5> <p>Those assessed as having a low risk of bias in this domain will include those where there was no missing outcome data; missing outcome data balanced in numbers across groups, with similar reasons for missing data across groups; and reasons for missing data unlikely to be related to true outcome. We will assess as unclear those trials were this outcome was not addressed and where there was insufficient reporting of attrition or exclusions, or both, to permit judgement of low or high risk. We will judge as high risk, e.g. those trials where reasons for missing data are likely to be related to the true outcome, with, e.g. imbalance in numbers or where 'as‐treated' analysis done with substantial departure of the intervention received from that assigned at randomisation. </p> </section> <section id="CD007843-sec-0057"> <h5 class="title">5. Selective outcome reporting</h5> <p>Those assessed as having a low risk of bias in this domain will include, e.g. where the trial protocol is available and where all the pre‐specified outcomes have been reported in the pre‐specified way. We will assess as unclear those trials where there is insufficient information to permit judgement of low or high risk. We will judge as high risk, e.g. those trials where not all of the trial's pre‐specified primary outcomes have been reported; and where one or more reported primary outcomes where not pre‐specified (unless clear justification provided). </p> </section> </section> <section id="CD007843-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>There were no data available for the included trial. For future updates of this review, when new trials are included, we will seek advice from the Cochrane Cystic Fibrosis and Genetic Diseases Group with regards to statistical analysis for data synthesis. To analyse the data we will use Review Manager 5 and report the results according to Cochrane criteria (<a href="./references#CD007843-bbs2-0028" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We plan to analyse binary data and report the risk ratio with corresponding 95% confidence intervals; we will analyse continuous outcomes and report mean differences between treatment groups and their 95% confidence intervals. </p> <p>Results of clinically homogeneous trials will be pooled to provide estimates of the efficacy of the interventions only if the included trials have similar interventions received by similar participants. Number needed to treat to benefit (NNTB) and number needed to treat to harm (NNTH) will be calculated for the whole pooled estimates with 95% confidence intervals. </p> </section> <section id="CD007843-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>For future updates of this review, should data are available for included trials, where trials measure data longitudinally, we plan to base the analysis on the final time‐point results. Methods are not yet available to carry out a meta‐analysis of aggregate longitudinal data, where individual patient data (IPD) are not available (<a href="./references#CD007843-bbs2-0022" title="JonesAP , RileyRD , WilliamsonPR , WhiteheadA . Meta‐analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clinical Trials2009;6(1):16‐27. ">Jones 2009</a>). </p> <p>If we are able to combine results from crossover trials we plan to use the methods recommended by Elbourne (<a href="./references#CD007843-bbs2-0014" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). However, if only limited data are available, we will only be able to either use the first‐arm data only or to treat the cross‐over trials as if they are parallel trials. Elbourne states that this approach will produce conservative results as it does not take into account within‐patient correlation (<a href="./references#CD007843-bbs2-0014" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). Also each participant will appear in both the treatment and control group, so the two groups will not be independent. We do not plan to combine data from parallel trials with data from cross‐over trials; these will be analysed separately. </p> </section> <section id="CD007843-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the trial authors of the PROACTIVE trial for further data and information, but to date have received no response (<a href="./references#CD007843-bbs2-0001" title="MillerST , KimHY , WeinerDL , WagerCG , GallagherD , StylesLA , et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion2013;53(4):704‐9. [CFGD Register: SC224c; 5500100000011225] NCT00951808 . Preventing Acute Chest Syndrome by Transfusion Feasibility Study (PROACTIVE). https://clinicaltrials.gov/ct2/show/NCT00951808 (accessed 03 February 2016). StylesL , Greene WagerC , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the predictive value of secretory phospholipase A2 in sickle cell disease patients with acute chest syndrome. Proceedings of the 53rd ASH Annual Meeting and Exposition; 2011 Dec 10‐13; San Diego, California. 2011. [Abstract No.: 846; CFGD Register: SC224a; 5500100000010732] StylesL , WagerCG , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). British Journal of Haematology2012;157(5):627‐36. [CFGD Register: SC224b; 5500100000010598] ">PROACTIVE 2012</a>). </p> <p>Should further trials be included in future updates, we will seek data for an intention‐to‐treat analysis, that is, data on the number of participants by allocated treated group, irrespective of compliance and whether or not the participant was later thought to be ineligible or otherwise excluded from treatment or follow‐up. </p> </section> <section id="CD007843-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>Should further trials be included in future updates, we will assess clinical heterogeneity by examining the characteristics of the trials; the similarity between the types of participants, the interventions and the outcomes as specified in the criteria for included trials. Statistical homogeneity will be assessed using a chi‐squared test and the I² statistic (<a href="./references#CD007843-bbs2-0020" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). We will use the following guidelines will be used for the interpretation of the I² values (<a href="./references#CD007843-bbs2-0012" title="DeeksJ , HigginsJ , AltmanD . Chapter 9 Analysing data and undertaking meta‐analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cocrane.org. ">Deeks 2011</a>): </p> <p> <ul id="CD007843-list-0006"> <li> <p>0% to 40%: might not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> </section> <section id="CD007843-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>Should further trials be included in future updates, in order to assess publication bias we will follow the recommendations on testing for funnel plot asymmetry only if there are at least 10 trials as described in section 10.4.3.1 of the<i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007843-bbs2-0030" title="SterneJ , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). If we detect asymmetry in the funnel plot, then we will investigate other possible causes. </p> <p>The authors will compare the protocol to the full trial publication to identify any reporting bias and therefore ensure that all outcomes measured are reported. If the full protocol is not available, we will at least compare the methods section of the full publication to the results section to ensure that all outcomes measured are reported.   </p> </section> <section id="CD007843-sec-0063"> <h4 class="title">Data synthesis</h4> <p>Should further trials be included in future updates, for the synthesis and meta‐analysis of any quantitative data we will use the fixed‐ and random‐effects models as appropriate. If we establish that there is significant heterogeneity between the trials we will use the random‐effects model. </p> <p>In the event that there are insufficient clinically homogeneous trials for this intervention or insufficient trial data that can be pooled a narrative synthesis will be presented. </p> </section> <section id="CD007843-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In order to investigate any heterogeneity identified, we plan to carry out subgroup analyses based on: </p> <p> <ol id="CD007843-list-0007"> <li> <p>age (children up to 18 years versus adults 18 years and older);</p> </li> <li> <p>SCD with thalassaemia versus those without thalassaemia;</p> </li> <li> <p>severity of SCD</p> <ol id="CD007843-list-0008"> <li> <p>severity will be assessed by using a Sickle Cell Severity Scale Scoring system when mentioned by trials </p> </li> <li> <p>clinical severity as mid, moderate or severe when mentioned by trial.</p> </li> </ol> </li> </ol> </p> </section> <section id="CD007843-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>If there are sufficient included trials, we intend conducting sensitivity analyses to assess the robustness of our review results by repeating the analysis with the following adjustments: exclusion of quasi‐randomised trials; exclusion of trials with unclear or inadequate allocation concealment; exclusion of trials with no or unclear blinding of outcomes assessment; and unclear or inadequate completeness of follow‐up. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007843-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007843-sec-0066"></div> <section id="CD007843-sec-0067"> <h3 class="title">Description of studies</h3> <section id="CD007843-sec-0068"> <h4 class="title">Results of the search</h4> <p>The search strategy retrieved 112 references. After examination of the titles and abstracts of them, we disregarded 10 references. Full text copies of the the remaining references were obtained and assessed independently by two authors. Any disagreement on the eligibility for this review was resolved through discussion and consensus. Further examination of the remaining 102 references (to six trials) resulted in us excluding five trials (98 references) and including one trial (four references). </p> </section> <section id="CD007843-sec-0069"> <h4 class="title">Included studies</h4> <p>One trial was eligible for inclusion in the review (<a href="./references#CD007843-bbs2-0001" title="MillerST , KimHY , WeinerDL , WagerCG , GallagherD , StylesLA , et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion2013;53(4):704‐9. [CFGD Register: SC224c; 5500100000011225] NCT00951808 . Preventing Acute Chest Syndrome by Transfusion Feasibility Study (PROACTIVE). https://clinicaltrials.gov/ct2/show/NCT00951808 (accessed 03 February 2016). StylesL , Greene WagerC , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the predictive value of secretory phospholipase A2 in sickle cell disease patients with acute chest syndrome. Proceedings of the 53rd ASH Annual Meeting and Exposition; 2011 Dec 10‐13; San Diego, California. 2011. [Abstract No.: 846; CFGD Register: SC224a; 5500100000010732] StylesL , WagerCG , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). British Journal of Haematology2012;157(5):627‐36. [CFGD Register: SC224b; 5500100000010598] ">PROACTIVE 2012</a>). Please refer to the '<a href="./references#CD007843-sec-0094" title="">Characteristics of included studies</a>' for further information on this trial. </p> <p>While in the multicentre PROACTIVE trial 237 people were enrolled (169 SCC, 42 SC, 15 Sβ⁰‐thalassaemia, 11Sβ<sup>+</sup>‐thalassaemia); the majority were recruited to an observational arm and only ten participants met the inclusion criteria for randomisation (<a href="./references#CD007843-bbs2-0001" title="MillerST , KimHY , WeinerDL , WagerCG , GallagherD , StylesLA , et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion2013;53(4):704‐9. [CFGD Register: SC224c; 5500100000011225] NCT00951808 . Preventing Acute Chest Syndrome by Transfusion Feasibility Study (PROACTIVE). https://clinicaltrials.gov/ct2/show/NCT00951808 (accessed 03 February 2016). StylesL , Greene WagerC , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the predictive value of secretory phospholipase A2 in sickle cell disease patients with acute chest syndrome. Proceedings of the 53rd ASH Annual Meeting and Exposition; 2011 Dec 10‐13; San Diego, California. 2011. [Abstract No.: 846; CFGD Register: SC224a; 5500100000010732] StylesL , WagerCG , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). British Journal of Haematology2012;157(5):627‐36. [CFGD Register: SC224b; 5500100000010598] ">PROACTIVE 2012</a>). Of these, four were randomised to the transfusion arm and received a single transfusion of 7 to 13 mL/kg packed red blood cells (PRBC), and six were randomised to standard care. None of the four participants who received packed red blood cells developed acute chest syndrome, while 33% (two participants) developed acute chest syndrome in standard care arm. </p> </section> <section id="CD007843-sec-0070"> <h4 class="title">Excluded studies</h4> <p>We excluded five trials (<a href="./references#CD007843-bbs2-0002" title="DolueeMT , KakhkiBR , MirHH , FateminayyeriM , MadanitorbatiF , HosseiniS , et al. Pain relief in the sickle‐cell crisis: intravenous morphine versus ketorolac; a double‐blind, randomized clinical trial. Iranian Red Crescent Medical Journal2019;21(4):e83614. ">Doluee 2019</a>; <a href="./references#CD007843-bbs2-0003" title="HeathLE , HeeneyMM , HoppeCC , AdjeiS , AgbenyegaT , BadrM , et al. Successful utilization of an electronic pain diary in a multinational phase 3. Clinical Trials2017;14(6):563‐71. [CFGD Register: SC298j] HeeneyM , HoppeC , AbboudM , InusaB , KanterJ , OgutuB , et al. Determining effects of platelet inhibition on vaso‐occlusive events (DOVE) trial: a double‐blind, placebo‐controlled, study of prasugrel in paediatric patients with sickle cell anaemia. Haematologica2016;101 Suppl 1:136‐7. [CFGD Register: SC298b] HeeneyMM , HoppeCC , AbboudMR , InusaB , KanterJ , OgutuB , et al. A multinational trial of prasugrel for sickle cell vaso‐occlusive events. New England Journal of Medicine2016;374(7):625‐35. [SC298a] HeeneyMM , HoppeCC , ReesDC . Prasugrel for sickle cell vaso‐occlusive events. New England Journal of Medicine2016;375(2):185‐6. [CFGD REgister: SC298h] HoppeCC , JakubowskiJA , FosterWM , HeathLE , PillaiS , PallavB . Candidate Gene Associations with Vaso‐Occlusive Crisis in Children with Sickle Cell Anemia Enrolled in the Multinational DOVE Trial. Blood2017;130(Supplement 1):962. [CFGD Register: SC298k] InusaB , ColombattiR , ReesDC , HeeneyMM , HoppeCC , OgutuB , et al. Geographic differences in phenotype and treatment of children with sickle cell anaemia from the multinational DOVE study. Blood. Conference: 58th annual meeting of the American society of hematology, ASH 2016. United states. Conference start: 20161203. Conference end: 201612062016;128(22):3653. [CFGD Register: SC298e] JakubowskiJA , HoppeCC , ZhouC , SmithBE , BrownPB , HeathLE , et al. Point of care platelet reactivity testing and dose‐titration in a double‐blind study of prasugrel in children with sickle cell anaemia. Haematologica2016;101 Suppl 1:585. [Abstract no.: E1412; CFGD Register: SC298c] JakubowskiJA , HoppeCC , ZhouC , SmithBE , BrownPB , HeathLE , et al. Real time dose adjustment utilizing point of care platelet reactivity testing in a double blind study of prasugrel in children with sickle cell anaemia (SCA). Thrombosis and Haemostasis2016;14 Suppl 1:113. [Abstract No.: PP19; SC298d] JakubowskiJA , HoppeCC , ZhouC , SmithBE , BrownPB , HeathLE , et al. Real‐time dose adjustment using point‐of‐care platelet reactivity testing in a double‐blind study of prasugrel in children with sickle cell anaemia. Thrombosis and Haemostasis2017;117(3):580‐8. [CFGD Register: SC298i] KanterJ , HeathLE , ZhouC , AgbenyegaT , ColombattiR , DampierC , et al. Regional‐and age‐related differences in pain in children with sickle cell anemia: results from the multinational DOVE study. Blood2016;128(22):3654. [CFGD Register: SC298f] ">DOVE 2017</a>; <a href="./references#CD007843-bbs2-0004" title="BeverungLM , StrouseJJ , HulbertML , NevilleK , LiemRI , InusaB , et al. Health‐related quality of life in children with sickle cell anemia: impact of blood transfusion therapy. American Journal of Hematology2015;90(2):139‐43. BhatnagarP , CasellaEB , ArkingDE , CasellaJF . Genome‐wide association for silent cerebral infarction (SCI) in sickle cell disease: the silent infarct transfusion trial (SIT) cohort. Blood2009;114(22):2563. BhatnagarP , PurvisS , Barron‐CasellaE , DeBaunMR , CasellaJF , ArkingDE , et al. Genome‐wide association study identifies genetic variants influencing F‐cell levels in sickle‐cell patients. Journal of Human Genetics2011;56(4):316‐23. BhatnagarP , PurvisS , Barron‐CasellaE , DeBaunMR , CasellaJF , ArkingDE , et al. Genome‐wide association study identifies genetic variants influencing F‐cell levels in sickle‐cell patients. Journal of Human Genetics2011;56(4):316‐23. Supplementary information. http://www.nature.com/jhg/journal/v56/n4/suppinfo/jhg201112s1.html. BundyDG , RichardsonTE , HallM , RaphaelJL , BrousseauDC , ArnoldSD , et al. Association of guideline‐adherent antibiotic treatment With readmission of children with sickle cell disease hospitalized with acute chest syndrome. JAMA Pediatrics2017;171(11):1090‐99. CasellaJF , KingAA , BartonB , WhiteDA , NoetzelMJ , IchordRN , et al. Design of the silent cerebral infarct transfusion (SIT) trial. Pediatric Hematology &amp; Oncology2010;27(2):69‐89. DeBaunMR , GordonM , McKinstryRC , NoetzelMJ , WhiteDA , SarnaikSA , et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. New England Journal of Medicine2014;371(8):699‐710. DeBaunMR , SarnaikSA , RodeghierMJ , MinnitiCP , HowardTH , IyerRV , et al. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood2012;119(16):3684‐90. Eigbire‐MolenO , DarbariDS , PonisioMR , MilchenkoMV , RodeghierMJ , CasellaJF , et al. Progressive loss of brain volume in children with sickle cell anemia: a report from the silent cerebral infarct transfusion trial cohort. Blood2015;126(23):546. GayJC , McCavitT , BundyD , KingA , LehmanHP , StrouseJJ , et al. Cost‐effectiveness of blood transfusions versus observation for silent cerebral infarcts from the silent cerebral infarct trial. Blood2016;128(22):3655. GlassbergJA , WangJ , CohenR , RichardsonLD , DeBaunMR . Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease. Academic Emergency Medicine2012;19(6):664‐72. ISRCTN52713285 . Silent Cerebral Infarct Multi‐Center Clinical Trial. www.isrctn.com/ISRCTN52713285 24 August 2004. [Protocol/ serial number: U01NS42804] KawadlerJM , ClarkCA , McKinstryRC , KirkhamFJ . Brain atrophy in paediatric sickle cell anaemia: findings from the silent infarct transfusion (SIT) trial. British Journal of Haematology2016; Vol. Apr 7 [Epub ahead of print]. [DOI: 10.1111/bjh.14039] KingAA , RodeghierMJ , PanepintoJA , StrouseJJ , CasellaJF , QuinnCT , et al. Silent cerebral infarction, income, and grade retention among students with sickle cell anemia. American Journal of Hematology2014;89(10):188‐92. [CFGD Register: SC184p] King , AA , StrouseJJ , RodeghierMJ , CompasBE , CasellaJF , McKinstryRC , et al. Parent education and biologic factors influence on cognition in sickle cell anemia. American Journal of Hematology2014;89(2):162‐7. KirkhamFJ , DarekarE , KijaR , BhadreshaR , McSwigganJ , CoxSE , et al. Brain T2‐weighted signal intensity ratio in children with sickle cell disease with and without stroke. European Journal of Paediatric Neurology2011;15 Suppl 1:S60. [Abstract no: P07.3] LandV , HeijboerH , FijnvandraatK , DeBaunMR , CasellaJF . Transfusions for silent cerebral infarcts in sickle cell anemia. New England Journal of Medicine2014;371(19):1841‐2. LiemRI , LiuJ , GordonMO , VendtBA , McKinstryRC3rd , KrautMA , et al. Reproducibility of detecting silent cerebral infarcts in pediatric sickle cell anemia. Journal of Child Neurology2014;29(12):1685‐91. NCT00072761 . Silent Cerebral Infarct Transfusion Multi‐Center Clinical Trial (SIT). clinicaltrials.gov/show/NCT00072761 Date first received: 10 November 2003. OgunsileFJ , DeBaunMR , CurrieK , RodeghierMJ . Parvovirus B19 infection associated with silent cerebral infarcts: a secondary analysis of the silent cerebral infarct trial cohort. Blood2015;126(23):3410. QuinnCT , McKinstryRC , DowlingMM , BallWS , KrautMA , CasellaJF , et al. Acute silent cerebral ischemia occurs more frequently than silent cerebral infarction in children with sickle cell anemia. Blood2010;116(21):268. RobertsDO , CovertB , RodeghierM , ParmarN , DeBaunMR , ThompsonAA , et al. Randomization is not associated with socio‐economic and demographic factors in a multi‐center clinical trial of children with sickle cell anemia. Pediatric Blood &amp; Cancer2014;61(9):1529‐35. ThangarajhM , YangG , FuchsD , PonisioMR , McKinstryRC , JajuA , et al. Magnetic resonance angiography‐defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose‐6‐phosphate dehydrogenase mutation in children with sickle cell anaemia. British Journal of Haematology2012;159(3):352‐9. VendtBA , McKinstryRC , BallWS , KrautMA , PriorFW , BartonB , et al. Silent cerebral infarct transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain. Journal of Digital Imaging2009;22(3):326‐43. WolfRB , SavilleBR , RobertsDO , FissellRB , KassimAA , AireweleG , et al. Factors associated with growth and blood pressure patterns in children with sickle cell anemia: Silent Cerebral Infarct Multi‐Center Clinical Trial cohort. American Journal of Hematology2015;90(1):2‐7. van derLandV , HeijboerH , FijnvandraatK , DeBaunMR , CasellaJF . Transfusions for silent cerebral infarcts in sickle cell anemia. New England journal of medicine2014;371(19):1841‐2. ">SIT 2014</a>; <a href="./references#CD007843-bbs2-0005" title="AbboudM , CureJ , GallagherD , BermanB , HsuL , WangW , et al. Magnetic resonance angiography (MRA) in children with abnormal transcranial doppler (TCD) velocities in the STOP study. Blood1999;94(10 Suppl 1):645a. AbboudMR , CureJ , GallagherD , BermanB , HsuL , WangW , et al. Magnetic resonance angiography in children with abnormal TCD in the STOP study. 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:49. AbboudMR , CureJ , GrangerS , GallagherD , HsuL , WangW , et al. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood2004;103(7):2822‐6. AdamkiewiczT , AbboudM , BarredoJ , CavalierME , PetersonJ , RackoffB , et al. Serum Ferritin in children with SCD on chronic transfusion: correlation with serum alanine aminotransferase and liver iron (STOP/STOP II liver iron ancillary study). 35th Annivesary Convention of the National Sickle Celll Disease Program and the Sickle Cell Disease Association of America; 2007 Sep 17‐22; Washington DC, USA. 2007:316. AdamkiewiczT , AbboudMR , BarredoJC , Kirby‐AllenM , AlvarezOA , CasellaJF , et al. Serum ferritin in children with sickle cell disease on chronic transfusion: measure of iron overload or end organ injury? STOP/ STOP II liver iron ancillary study. Blood. 2006; Vol. 108, issue 11. [Abstract no: 791] AdamkiewiczTV , AbboudMR , PaleyC , OlivieriN , Kirby‐AllenM , VichinskyE , et al. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood2009;114(21):4632‐8. AdamsR , FullertonH , KwiatkowskiJ , VoeksJ . Development of high risk TCD in sickle cell disease. Stroke; a journal of cerebral circulation2015;46(Suppl 1):Abstract no: 17. AdamsRJ . Lessons from the stroke prevention trial in sickle cell anemia (STOP) study. Journal of Child Neurology2000;15(5):344‐9. [NCT00000592: Stroke Prevention in Sickle Cell Anemia (STOP 1)] AdamsRJ , BrambillaDJ . Stroke prevention trial in sickle cell anemia: STOP. 21st Annual Meeting of the National Sickle Cell Disease Program. 1996:19. AdamsRJ , BrambillaDJ , GrangerS , GallagherD , VichinskyE , AbboudMR , et al. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood2004;103(10):3689‐94. AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Risk of stroke in children with sickle cell disease and abnormal transcranial doppler ultrasound (TCD). Blood1999;94(10 Suppl 1):419a. AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): Baseline characteristics of trial patients. 22nd Annual Meeting of the National Sickle Cell Disease Program. 1997:41. AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): final results. 25th Annual Meeting of the National Sickle Cell Disease Program. 2001. [Abstract no: #8] AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): final results. Blood2000;96(11 Pt 1):10a. AdamsRJ , BrambillaDJ , McKieV , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): follow‐up after closure of the trial. Blood1998;92(10 Suppl 1):527a. AdamsRJ , BrambillaDJ , McKieVC , FilesB , VichinskyE , AbboudM , et al. Stroke prevention in sickle cell disease (STOP): baseline characteristics of trial patients. Blood1997;90(10 Suppl 1):123a. AdamsRJ , BrambillaDJ , VichinskyE , AbboudM , PegelowC , CarlEM , et al. Risk of stroke and conversion to abnormal TCD in children screened with transcranial doppler (TCD) during the STOP study. National Sickle Cell Disease Program 30th Annual Meeting; 2002 Sept 17‐21. 2002:3. AdamsRJ , BrambillaDJ , VichinskyE , AbboudM , PegelowC , CarlEM , et al. Stroke prevention trial in sickle cell anemia (STOP study): Risk of stroke in 1933 children screened with transcranial doppler (TCD). 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:54. AdamsRJ , CarlEM , McKieVC , OdoNA , KutlarA , PhillipsM , et al. A pilot trial of hydroxyurea to prevent strokes in children with sickle cell anemia. 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:53. AdamsRJ , LacklandDT , BrownL , BrownD , VoeksJ , FullertonHJ , et al. Transcranial Doppler Re‐screening of Subjects who Participated in STOP and STOP. American journal of hematology2016;91(12):1191‐4. AdamsRJ , McKieV , FilesB , VichinskyE , AbboudM , HsuL , et al. Stroke prevention in sickle cell disease (STOP): Results of transcranial doppler ultrasound screening stroke risk. Stroke1998;29(1):308. AdamsRJ , McKieVC , BrambillaDJ , CarlE , GallagherD , NicholsFT , et al. Stroke prevention trial in sickle cell anemia. Controlled Clinical Trials1998;19(1):110‐29. AdamsRJ , McKieVC , HsuL , FilesB , VichinskyE , PegelowC , et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. New England Journal of Medicine1998;339(1):5‐11. [NCT00000592: Stroke Prevention in Sickle Cell Anemia (STOP 1)] Anonymous . Transfusion to prevent first stroke in children with sickle cell anemia. Journal of the American Ostoepathic Association1998;98(7):363‐4. BulasDI , JonesA , SeibertJJ , DriscollC , O'DonnellR , AdamsRJ . Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatric Radiology2000;30(11):733‐8. CohenAR . Sickle cell disease ‐ new treatments, new questions. New England Journal of Medicine1998;339(1):42‐4. DuncanGW . Ischemic stroke in sickle cell disease: a review. Tennessee Medicine1997;90(12):498‐9. FilesB , BrambillaD , KutlarA , MillerS , PegelowC , VichinskyE , et al. A randomized trial of chronic transfusion to prevent stroke in sickle cell anemia: changes in ferritin with chronic transfusion. Blood1998;92(10 Suppl 1):528a. FilesB , BrambillaD , KutlarA , MillerS , VichinskyE , WangW , et al. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). Journal of Pediatric Hematology/Oncology2002;24(4):284‐90. GatesA , RogersMA , PuczynskiM . Stroke prevention trial in sickle cell anemia: comments on effects of chronic transfusion on pain. Journal of Pediatrics2002;141(5):742‐3. HsuLL , MillerST , WrightE , KutlarA , McKieV , WangW , et al. Alpha thalassemia is associated with decreased risk of abnormal transcranial doppler ultrasonography in children with sickle cell anemia. Journal of Pediatric Hematology/Oncology2003;25(8):622‐8. HyacinthHI , GeeBE , VoeksJH , AdamsRJ , HibbertJ . High frequency of RBC transfusions in the STOP study was associated with reduction in serum biomarkers of neurodegeneration, vascular remodeling and inflammation. Blood. 2012; Vol. 120, issue 21. [Abstract no: 244; CENTRAL: 999896; CRS: 5500127000000021] KanterJ , KwiatkowskiJ , FullertonHJ , VoeksJ , DebenhamE , BrownLJ , et al. Impact of TCD screening protocol on the incidence of hemorrhagic stroke in children and young adults with sickle cell disease. Blood2015;126(23):3402. KutlarA , BrambillaD , ClairB , HaghighatA , BakanayS , AdamsG , et al. Candidate gene polymorphisms and their association with TCD velocities in children with sickle cell disease. Blood. 2007; Vol. 110, issue 11. [Abstract no: 429] KutlarA , HarbinJ , JacksonB , HolleyL , GallagherD , ClairB , et al. Laboratory parameters in patients randomized in the STOP study and their modification by transfusion. Blood2000;96(11 Pt 2):18b‐9b. KutlarA , HarbinJ , JacksonBB , HolleyLGD , ClairB , BrambillaD , et al. Baseline laboratory parameters in patients randomized to the STOP study and their modification by transfusion. 24th Annual Meeting of the National Sickle Cell Disease Program. 2000:82a. KwiatkowskiJL , BrambillaDJ , GrangerS , AdamsRJ . Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease. Blood. 2003; Vol. 102, issue 11. [Abstract no: 408] KwiatkowskiJL , GrangerS , BrambillaDJ , BrownRC , MillerST , AdamsRJ . Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. British Journal of Haematology2006;134(3):333‐9. KwiatkowskiJL , KanterJ , FullertonHJ , VoeksJ , DebenhamE , BrownDG , et al. Ischemic stroke in children and young adults with sickle cell disease (SCD) in the post‐stop era. Blood2015;126(23):68. [CFGD Register: SC4fff, SC185q] KwiatkowskiJL , MoralesK , BrambillaDJ , FilesB , AdamkiewiczT , AdamsRJ . Long‐term follow‐up of transcranial doppler ultrasonography in children with sickle cell disease: Results of the STOP and STOP II patient cohorts. Blood2002;100(11 Pt 1):663a. LeeMT , PiomelliS , GrangerS , MillerST , HarknessS , BrambillaDJ , et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow‐up and final results. Blood2006;108(3):847‐52. LeeSB , RamsinghD , KutlarA , HolleyL , McVieVC , AdamsRJ . C‐reactive protein in children with sickle cell disease at risk for stroke in the STOP study. Stroke2002;33(1):373. LezcanoNE , OdoN , KutlarA , BrambillaD , AdamsRJ . Regular transfusion lowers plasma free hemoglobin in children with sickle‐cell disease at risk for stroke. Stroke2006;37(6):1424‐6. [CFGD Register: SC4uu] LezcanoNE , OdoN , KutlarA , BrambillaD , AdamsRJ . Transfusion lowers plasma‐free hemoglobin in children with sickle cell disease at risk for stroke. Stroke2006;37(2):695‐6. [CFGD Register: SC4ggg] MillerST , WrightE , AbboudM , BermanB , FilesB , ScherC , et al. Impact of chronic transfusion on non‐neurological events during the Stroke Prevention Trial in sickle cell anemia (STOP). Pediatric Research2000;47(4 Pt 2):251A. MillerST , WrightE , AbboudM , BermanB , FilesB , ScherC , et al. Impact of chronic transfusion on non‐neurological events during the stroke prevention trial in sickle cell anemia (TOP). 24th Annual Meeting of the National Sickle Cell Disease Program. 2000:61a. MillerST , WrightE , AbboudM , BermanB , FilesB , ScherCD , et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle‐cell anemia. Journal of Pediatrics2001;139(6):785‐9. NicholsFT , JonesAM , AdamsRJ . Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing. Journal of Neuroimaging2001;11(4):354‐62. OlivieriN , BrambillaD , McKieV , PiomelliS , KutlarA , FilesB , et al. Changes in cerebral blood flow velocities during chronic transfusion therapy to prevent stroke in sickle cell disease. Blood2000;96(11 Pt 1):486a. PegelowCH , AdamsR , HsuL , McKieV , WangW , ZimmermanR , et al. Children with silent infarct and elevated transcranial doppler ultrasonography velocity are at increased risk of subsequent infarctive events. 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:137. PegelowCH , WangW , GrangerS , HsuLL , VichinskyE , MoserFG , et al. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Archives of Neurology2001;58(12):2017‐21. SarnaikSA . Prevention of stroke by transfusions in children with sickle cell anemia. New England journal of medicine1998;339:1477‐8. SayerG , BowmanL , ClairB , CailA , BlanchardB , NatrajanK , et al. Long term outcome of patients enrolled into STOP and STOP II trials: a single center experience. Blood. 2012; Vol. 120, issue 21. [Abstract no: 3219; CENTRAL: 999895; CRS: 5500127000000020] StylesL , DeJongK , VichinskyE , LubinB , AdamsR , KuypersF . Increased RBC phosphatidylserine exposure in sickle cell disease patients at risk for stroke by transcranial Doppler screening. Blood1997;90(10 Suppl 1):604a‐5a. VichinskyE , LubanE , WrightE , OlivieriN , DriscollC , PegelowC , et al. Prospective red cell phenotype matching in STOP ‐ a multi‐centre transfusion trial. 23rd Annual Meeting of the National Sickle Cell Disease Program. 1999:163. VichinskyE , LubanN , WrightE , OlivieriN , DriscollC , PegelowC , et al. Prospective red cell phenotype matching in STOP ‐ a multi‐center transfusion trial. Blood1998;92(10 Suppl 1):528a. VichinskyEP , LubanNL , WrightE , OlivieriN , DriscollC , PegelowCH , et al. Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion2001;41(9):1086‐92. WangW , MoralesK , OlivieriN , StylesL , ScherC , AdamsR , et al. Effect of chronic transfusion on growth in children with sickle cell anemia: results of the STOP trial. National Sickle Cell Disease Program 30th Annual Meeting Conference; 2002 Sept 17‐21. 2002:100. WangWC , MoralesKH , ScherCD , StylesL , OlivieriN , AdamsR , et al. Effect of long‐term transfusion on growth in children with sickle cell anemia: results of the STOP trial. Journal of Pediatrics2005;147(2):244‐7. ">STOP 1998</a>; <a href="./references#CD007843-bbs2-0006" title="StylesLA , AbboudM , LarkinS , LoM , KuyperFA . Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Proceedings of the 27th Annual Meeting of the National Sickle Cell Disease Program; 2004 Apr 18‐21; Los Angeles. 2004:72. [CFGD Register: SC174a] StylesLA , AbboudM , LarkinS , LoM , KuypersFA . Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. British Journal of Haematology2006;136(2):343‐4. [CFGD Register: SC174b] ">Styles 2006</a>). These studies did not meet our inclusion criteria and noted the reasons for their exclusion are available in the '<a href="./references#CD007843-sec-0095" title="">Characteristics of excluded studies</a>' table. </p> </section> </section> <section id="CD007843-sec-0071"> <h3 class="title">Risk of bias in included studies</h3> <p>One clinical trial was included in this review; this trial had some limitations with regard to the randomised component of the study (<a href="./references#CD007843-bbs2-0001" title="MillerST , KimHY , WeinerDL , WagerCG , GallagherD , StylesLA , et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion2013;53(4):704‐9. [CFGD Register: SC224c; 5500100000011225] NCT00951808 . Preventing Acute Chest Syndrome by Transfusion Feasibility Study (PROACTIVE). https://clinicaltrials.gov/ct2/show/NCT00951808 (accessed 03 February 2016). StylesL , Greene WagerC , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the predictive value of secretory phospholipase A2 in sickle cell disease patients with acute chest syndrome. Proceedings of the 53rd ASH Annual Meeting and Exposition; 2011 Dec 10‐13; San Diego, California. 2011. [Abstract No.: 846; CFGD Register: SC224a; 5500100000010732] StylesL , WagerCG , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). British Journal of Haematology2012;157(5):627‐36. [CFGD Register: SC224b; 5500100000010598] ">PROACTIVE 2012</a>). No information on any domain of risk of bias was provided in the published papers. The first and main limitation was the small number of participants, so the trial would obviously be judged to have a high risk of bias given the lack of people recruited. The randomised component of this study provided only a little information. Also the impact of fluid administration on the course of a pain episode in different centres is unknown. Further restriction of fluid by investigators among clinical centres might further reduce the incidence of nosocomial ACS. </p> </section> <section id="CD007843-sec-0072"> <h3 class="title" id="CD007843-sec-0072">Effects of interventions</h3> <p>One trial was eligible for inclusion in the review (<a href="./references#CD007843-bbs2-0001" title="MillerST , KimHY , WeinerDL , WagerCG , GallagherD , StylesLA , et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion2013;53(4):704‐9. [CFGD Register: SC224c; 5500100000011225] NCT00951808 . Preventing Acute Chest Syndrome by Transfusion Feasibility Study (PROACTIVE). https://clinicaltrials.gov/ct2/show/NCT00951808 (accessed 03 February 2016). StylesL , Greene WagerC , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the predictive value of secretory phospholipase A2 in sickle cell disease patients with acute chest syndrome. Proceedings of the 53rd ASH Annual Meeting and Exposition; 2011 Dec 10‐13; San Diego, California. 2011. [Abstract No.: 846; CFGD Register: SC224a; 5500100000010732] StylesL , WagerCG , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). British Journal of Haematology2012;157(5):627‐36. [CFGD Register: SC224b; 5500100000010598] ">PROACTIVE 2012</a>) The effects of blood transfusions for treating acute chest syndrome could not be determined from the one very small eligible trial; there were no sufficient data that could be presented within this review. Therefore the synthesis and meta‐analysis of quantitative data were not performed. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007843-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007843-sec-0073"></div> <section id="CD007843-sec-0074"> <h3 class="title" id="CD007843-sec-0074">Summary of main results</h3> <p>The comprehensive search in this review provided only one eligible trial. The trial was a feasibility study consisted of an observational arm and a randomised arm (10 participants). Therefore there is not enough evidence to support the effectiveness of blood transfusions for treating acute chest syndrome (<a href="./references#CD007843-bbs2-0001" title="MillerST , KimHY , WeinerDL , WagerCG , GallagherD , StylesLA , et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion2013;53(4):704‐9. [CFGD Register: SC224c; 5500100000011225] NCT00951808 . Preventing Acute Chest Syndrome by Transfusion Feasibility Study (PROACTIVE). https://clinicaltrials.gov/ct2/show/NCT00951808 (accessed 03 February 2016). StylesL , Greene WagerC , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the predictive value of secretory phospholipase A2 in sickle cell disease patients with acute chest syndrome. Proceedings of the 53rd ASH Annual Meeting and Exposition; 2011 Dec 10‐13; San Diego, California. 2011. [Abstract No.: 846; CFGD Register: SC224a; 5500100000010732] StylesL , WagerCG , LabotkaRJ , Smith‐WhitleyK , ThompsonAA , LanePA , et al. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). British Journal of Haematology2012;157(5):627‐36. [CFGD Register: SC224b; 5500100000010598] ">PROACTIVE 2012</a>). </p> </section> <section id="CD007843-sec-0075"> <h3 class="title" id="CD007843-sec-0075">Overall completeness and applicability of evidence</h3> <p>Although the PROACTIVE trial was multi‐institutional, involving centres with large sickle cell populations and high expertise in the care of this population, the small numbers of people with SCD enrolled in the PROACTIVE randomised clinical trial precluded any assessment of the effectiveness of blood transfusion to prevent acute chest syndrome in this population. </p> </section> <section id="CD007843-sec-0076"> <h3 class="title" id="CD007843-sec-0076">Quality of the evidence</h3> <p>The risk of bias of the included trial trial is unclear and the numbers recruited were very small with no data available on any of the reviews pre‐defined outcomes. </p> </section> <section id="CD007843-sec-0077"> <h3 class="title" id="CD007843-sec-0077">Agreements and disagreements with other studies or reviews</h3> <p>Over the last 20 years there have been a number of relevant studies one of which was the STOP trial which sought to illustrate the effectiveness of blood transfusions for prevention of stroke (<a href="./references#CD007843-bbs2-0007" title="AdamsRJ , McKieVC , HsuL , FilesB , VichinskyE , et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. New England Journal of Medicine1998;339(1):5‐11. ">Adams 1998</a>). Although this randomised controlled trial focused on blood transfusions for prevention of first stroke it also provided some limited data on the possible impact of blood transfusions on reducing the incidence of ACS, but questions still remain unanswered as to whether treatment options for ACS based on these interventions can be considered both effective and safe. No firm conclusions can be drawn at the present time about the effectiveness or otherwise of blood transfusions. In line with this trial, a few trials were enrolled by the title of Post‐STOP, which aimed to follow‐up the included Sickel Cell Childrens from different points of view. Another comprehensive trail was designed as Silent Cerebral Infarct Transfusion Trial Cohort (SIT), in children with Sickle Cell Anemia. The main outcome of this study was the efficacy of blood transfusion therapy for prevention of recurrent silent cerebral infarcts in participants with SCA.This outcome was far from the aims of our systematic review. Also the Silent Cerebral Infarct Transfusion Trial (SIT) tested the following hypothesis: prophylactic blood transfusion therapy in children with SCI result in at least an 86% reduction in the rate of subsequent overt strokes or new or progressive cerebral infarcts as defined by magnetic resonance imaging (MRI) of the brain. So the outcome and intervention were far from the aims of our systematic review. </p> </section> </section> </section> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007843.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"/> </noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007843-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007843-note-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007843-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD007843-note-0001">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007843-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"/> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007843\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007843\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007843\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007843\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007843\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=nnwvukoo&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007843.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007843.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007843.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007843.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007843.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728386053"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007843.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728386057"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007843.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec337ec469367',t:'MTc0MDcyODM4Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 